Efavirenz-associated breast hypertrophy in HIV-infected patients
- 1 January 2001
- journal article
- case report
- Published by Wolters Kluwer Health in AIDS
- Vol. 15 (1) , 126-129
- https://doi.org/10.1097/00002030-200101050-00021
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort studyThe Lancet, 1999
- Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapineAIDS, 1999
- Lipodystrophy in patients naive to HIV protease inhibitorsAIDS, 1999
- Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapyAIDS, 1999
- Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patientsAIDS, 1998
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- Visceral abdominal-fat accumulation associated with use of indinavirThe Lancet, 1998
- “Buffalo hump” in men with HIV-1 infectionThe Lancet, 1998
- Leydig Cell Tumour in a Man with Human Immunodeficiency VirusScandinavian Journal of Urology and Nephrology, 1995
- GynecomastiaNew England Journal of Medicine, 1993